Viewing StudyNCT03546894



Ignite Creation Date: 2024-05-06 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 12:47 PM
Study NCT ID: NCT03546894
Status: COMPLETED
Last Update Posted: 2024-07-15
First Post: 2018-05-23

Brief Title: A Study to Determine Progression-free Survival PFS and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive ALK Non-Small Cell Lung Cancer NSCLC Treated With Anaplastic Lymphoma Kinase ALK Inhibitors
Sponsor: Takeda
Organization: Takeda

Conditions & Keywords Data

Conditions:
Name
Anaplastic Lymphoma Kinase-positive
Carcinoma Non-small-cell Lung
Keywords:
Name View
Drug Therapy View